About CHU Frantz FANON
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
El Kendi Pharmaceuticals Manufacturing Company
1
European Cardiovascular Research Center
1
Hikma Pharmaceuticals LLC
1
Clinical Trials at CHU Frantz FANON
During the past decade, CHU Frantz FANON conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluate Efficacy of the Association Nimotuzumab(HR3) /Cisplatin-Vinorelbine on Patients With Cervical Carcinom
2015-11-01
2021-02-01
Completed
37
Effectiveness and Safety of Generic Delayed-Release Dimethyl Fumarate (Sclera® or Marovarex ®, Hikma) in Routine Medical Practice in the Treatment of Relapsing-Remitting Multiple Sclerosis in MENA Region
2021-02-23
2023-07-01
Active, not recruiting
155
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Frantz FANON"
#1 collaborator was "Comed B.V." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at CHU Frantz FANON
According to Clinical.Site data, the most researched conditions in "CHU Frantz FANON" are
"Atrial Septal Defects" (1 trials), "Cervical Cancer" (1 trials), "Patent Ductus Arteriosus" (1 trials) and "Relapsing Remitting Multiple Sclerosis" (1 trials). Many other conditions were trialed in "CHU Frantz FANON" in a lesser frequency.
Clinical Trials Intervention Types at CHU Frantz FANON
Most popular intervention types in "CHU Frantz FANON" are "Biological" (1 trials), "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "ASD and PDA closure" (1 trials), "Dimethyl Fumarate (DMF)" (1 trials), "Nimotuzumab ( h-R3)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CHU Frantz FANON
The vast majority of trials in "CHU Frantz FANON" are
2 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at CHU Frantz FANON
Currently, there are NaN active trials in "CHU Frantz FANON".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in CHU Frantz FANON,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CHU Frantz FANON, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".